Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

EKO International Corp. (EKNL)

0.0000
0.0000
(0.00%)
At close: April 30 at 4:00:00 PM EDT
Loading Chart for EKNL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0000
  • Volume 38,302
  • Avg. Volume 0
  • Market Cap (intraday) 114,692
  • Beta (5Y Monthly) 1.15
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

EKO International Corp., through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. The company, through its joint venture interest in NeuroVasc Clinical Inc., also sets up and/or manage clinics to treat patients using FREMSTM equipment. EKO International Corp. is based in Burlington, Canada.

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EKNL

View More

Performance Overview: EKNL

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EKNL
0.00%
S&P 500 (^GSPC)
5.31%

1-Year Return

EKNL
0.00%
S&P 500 (^GSPC)
10.59%

3-Year Return

EKNL
99.75%
S&P 500 (^GSPC)
34.78%

5-Year Return

EKNL
99.52%
S&P 500 (^GSPC)
91.22%

Compare To: EKNL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EKNL

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    -970.19k

  • Net Income Avi to Common (ttm)

    30.88k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    38.87k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: EKNL

View More

Company Insights: EKNL

Research Reports: EKNL

View More

People Also Watch